10-Q: Chicago Atlantic Real Estate Finance Q1 2026 Earnings

Chicago Atlantic Real Estate Finance reports a decrease in net income for Q1 2026 compared to Q1 2025, primarily due to a significant increase in the provision for expected credit losses.

Summary

• Chicago Atlantic Real Estate Finance, Inc. (REFI) reported its financial results for the first quarter ended March 31, 2026.
• Net income decreased by 52% to $4.84 million from $10.04 million in the same period last year.
• This decrease was largely driven by a substantial increase in the provision for current expected credit losses, which rose to $3.84 million from a benefit of $1.07 million in the prior year's quarter.
• Total expenses increased by 169% to $8.08 million, primarily due to the higher credit loss provision.
• Net interest income saw a slight increase of 1% to $13.12 million.
• The company's loan portfolio stood at $413.6 million in principal outstanding as of March 31, 2026, with a weighted-average yield-to-maturity IRR of 15.8%.
• The company declared a regular cash dividend of $0.47 per share for the first quarter of 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to the significant decrease in net income and the substantial increase in credit loss provisions, despite some positive operational metrics and consistent dividend payments.

Positives

• Net interest income increased by 1% to $13.12 million.
• The company's loan portfolio has a weighted-average yield-to-maturity IRR of 15.8%.
• The company declared a regular cash dividend of $0.47 per share, consistent with the prior year's first quarter dividend.
• The company is in compliance with all financial covenants for its revolving loan and unsecured notes.
• Loan #9 was restored to accrual status as of March 31, 2026, indicating improved borrower performance.
• The company has $27.9 million in cash and cash equivalents as of March 31, 2026, an increase from $14.9 million at the end of 2025.

Negatives

• Net income decreased by 52% to $4.84 million compared to $10.04 million in Q1 2025.
• The provision for current expected credit losses increased significantly to $3.84 million from a benefit of $1.07 million in Q1 2025.
• Total expenses increased by 169% to $8.08 million, largely due to the increased credit loss provision.
• The weighted-average yield-to-maturity IRR on the loan portfolio decreased from 16.3% at December 31, 2025, to 15.8% at March 31, 2026.
• The CECL reserve increased by $3.8 million to $8.68 million as of March 31, 2026, representing 2.15% of principal on loans held for investment, up from 1.23% at December 31, 2025.
• Loans rated '4' (high risk/potential for loss) increased to 9.1% of the portfolio carrying value, up from 4.8% at the end of 2025.
• Loans rated '5' (impaired/loss likely) now represent 1.6% of the portfolio carrying value, up from 0% at the end of 2025.

Risks

• The federal illegality of cannabis poses risks to borrowers, potentially leading to strict enforcement actions.
• Borrowers may be unable to renew or maintain their licenses for cannabis operations.
• The lack of liquidity in cannabis-related loans could lead to significant losses.
• New laws adverse to cannabis borrowers may be enacted, or current favorable laws may be modified or eliminated.
• The company may be prohibited from owning cannabis assets if a loan defaults or is seized, impacting collateral recovery.
• The company's ability to grow or maintain its business depends on evolving state laws pertaining to the cannabis industry.
• The rescheduling of medical cannabis to Schedule III by the DEA introduces uncertainty regarding its practical application to integrated businesses and potential impacts on Section 280E of the Code.
• Increased competition from other capital providers due to cannabis rescheduling could result in compressed lending spreads and reduced origination opportunities.
• Interest rate mismatches between floating-rate assets and borrowings could adversely affect profitability.
• Concentration in the loan portfolio, with the top three borrowers representing 33.2% of principal outstanding as of March 31, 2026.

Future Outlook

The company expects to continue to grow its loan portfolio by recycling capital from loan paydowns, repayments, and sales of common stock. It anticipates needing to raise additional equity and/or debt financing to increase liquidity. The company believes its current cash on hand, revolving loan capacity, and operational cash flows will be sufficient for the next twelve months.

Management Comments

• The company believes that favorable market conditions, including an imbalance in supply and demand of credit to cannabis operating companies, have provided attractive opportunities for non-bank lenders.
• The Manager seeks to invest in transactions that tend to be attractively priced and have stronger than normal covenants and amortization due to the complexity of the industry.
• The company believes that cannabis operators' limited access to traditional financing has provided attractive opportunities to make loans to companies with strong fundamentals but requiring customized financing structures.
• Management restored Loan #9 to accrual status as of March 31, 2026, as the borrower demonstrated sustained ability to meet debt service obligations.
• Management kept Loan #36 on accrual status as of March 31, 2026, after collecting all past due interest in early April 2026.

Industry Context

StockSavvy.ai notes that Chicago Atlantic Real Estate Finance's Q1 2026 results reflect the ongoing challenges and opportunities within the cannabis lending sector. The significant increase in the CECL reserve highlights the inherent credit risks associated with this industry, while the company's continued focus on specialized financing and its ability to secure attractive yields demonstrate its strategic positioning. The recent DEA rescheduling of medical cannabis introduces both potential benefits (e.g., reduced tax burden for some borrowers) and complexities, creating an evolving regulatory landscape that the company is actively monitoring.

Comparison to Industry Standards

• The weighted-average yield-to-maturity IRR of 15.8% for Chicago Atlantic's loan portfolio is generally higher than typical commercial real estate debt yields, reflecting the higher risk profile of the cannabis industry.
• The increase in the CECL reserve to 2.15% of principal is a significant indicator of credit risk, which may be higher than the average for diversified commercial real estate lenders but potentially in line with or higher than other specialized cannabis lenders.
• The company's focus on senior secured loans secured by real estate, equipment, and licenses aligns with common practices in specialized lending, but the specific collateral mix and borrower profiles are unique to the cannabis sector.
• The company's dividend yield, implied by the $0.47 quarterly dividend and a stock price around $11.32 (as of March 31, 2026), suggests a yield that is competitive within the REIT sector, particularly for those focused on higher-yielding, albeit riskier, asset classes.

Legal Proceedings

• The company is not aware of any legal claims that could materially impact its business, financial condition, or results of operations as of March 31, 2026.

Related Party Transactions

• The company is externally managed by Chicago Atlantic REIT Manager, LLC (the Manager), which is wholly-owned by Chicago Atlantic Group, LP (the Sponsor).
• The Manager is entitled to base management fees and incentive compensation.
• For the three months ended March 31, 2026, total management and incentive fees earned were $1.72 million.
• General and administrative expenses reimbursable to the Manager totaled $1.03 million for the three months ended March 31, 2026.
• Loan #9, a related party loan with a carrying value of $29.0 million as of March 31, 2026, was restored to accrual status.
• Loan #18 (FRX) is a related party loan with a carrying value of $47.8 million as of March 31, 2026.

Stakeholder Impact

• Shareholders: A decrease in net income and an increase in credit loss provisions may raise concerns about future profitability and dividend sustainability, although the dividend was maintained at $0.47 per share.
• Creditors: The company's compliance with financial covenants on its revolving loan and unsecured notes is positive for creditors.
• Employees: Stock-based compensation expense increased, reflecting ongoing equity awards to employees of the Manager.
• Borrowers: The increased CECL reserve and focus on risk mitigation may lead to more stringent underwriting or loan modification terms.
• Regulators: The company's operations are subject to evolving cannabis regulations at both state and federal levels, particularly following the DEA's rescheduling of medical cannabis.

Next Steps

• Continue to monitor the legal and regulatory landscape surrounding the cannabis industry, particularly in light of the DEA's rescheduling order.
• Actively manage the loan portfolio, assessing borrower performance and credit quality.
• Evaluate opportunities to raise additional equity and/or debt financing to increase liquidity.
• Continue to recycle capital from loan paydowns, repayments, and potential equity sales.
• Monitor the impact of the DEA's rescheduling of medical cannabis on borrowers and the broader industry.

Key Dates

Recommendation

While the company maintains its dividend and has a strong yield-to-maturity on its loan portfolio, the significant increase in credit loss provisions and the resulting decrease in net income are concerning. The evolving regulatory landscape for cannabis also introduces uncertainty. A 'hold' recommendation is appropriate given the mixed signals, pending further clarity on credit quality trends and the impact of regulatory changes.

Keywords

Chicago Atlantic Real Estate Finance, REFI, 10-Q, Quarterly Report, Cannabis Lending, Commercial Real Estate, Mortgage REIT, CECL, Credit Losses, Interest Income, Loan Portfolio, REIT